ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Cybergu
|
2.4K |
777K |
4 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
2.4K
|
777K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Market Update - Progress Report
|
|
Cybergu
|
199 |
62K |
5 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
199
|
62K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
Cybergu
|
1.3K |
593K |
3 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
1.3K
|
593K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 OEM Contracts (various)
|
|
Cybergu
|
50 |
18K |
2 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
50
|
18K
|
2
|
|
ASX - By Stock
|
HUM |
Re:
The reason why FXL is NOT a BNPL company
|
|
Cybergu
|
254 |
50K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
254
|
50K
|
0
|
|
ASX - By Stock
|
HUM |
Re:
The reason why FXL is NOT a BNPL company
|
|
Cybergu
|
254 |
50K |
4 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
254
|
50K
|
4
|
|
ASX - By Stock
|
HUM |
Re:
The reason why FXL is NOT a BNPL company
|
|
Cybergu
|
254 |
50K |
0 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
254
|
50K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
Cybergu
|
76 |
25K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
Cybergu
|
76 |
25K |
4 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
Cybergu
|
76 |
25K |
2 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
Cybergu
|
76 |
25K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
Cybergu
|
76 |
25K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Pause in Trading
|
|
Cybergu
|
21 |
4.5K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
21
|
4.5K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Pause in Trading
|
|
Cybergu
|
21 |
4.5K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
21
|
4.5K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives TGA approval for COVID19 antibody test
|
|
Cybergu
|
136 |
47K |
3 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
136
|
47K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
Cybergu
|
438 |
149K |
14 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
438
|
149K
|
14
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: DIVOC Labs to sell Atomo's COVID-19 test in India
|
|
Cybergu
|
88 |
25K |
4 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
88
|
25K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: DIVOC Labs to sell Atomo's COVID-19 test in India
|
|
Cybergu
|
88 |
25K |
2 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
88
|
25K
|
2
|
|
ASX - By Stock
|
AKP |
Re:
AKP Chart Thread
|
|
Cybergu
|
379 |
156K |
1 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
379
|
156K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
Cybergu
|
438 |
149K |
5 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
438
|
149K
|
5
|
|
ASX - By Stock
|
AKP |
Re:
AKP Chart Thread
|
|
Cybergu
|
379 |
156K |
4 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
379
|
156K
|
4
|
|
ASX - By Stock
|
HUM |
Re:
open price Friday
|
|
Cybergu
|
159 |
54K |
0 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
159
|
54K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 OEM Contracts (various)
|
|
Cybergu
|
50 |
18K |
5 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
50
|
18K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
Cybergu
|
438 |
149K |
2 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
438
|
149K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: FY20 Results Presentation
|
|
Cybergu
|
86 |
26K |
4 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
86
|
26K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: FY20 Results Presentation
|
|
Cybergu
|
86 |
26K |
7 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
86
|
26K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: FY20 Results Presentation
|
|
Cybergu
|
86 |
26K |
2 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
86
|
26K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: FY20 Results Presentation
|
|
Cybergu
|
86 |
26K |
5 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
86
|
26K
|
5
|
|
ASX - By Stock
|
HUM |
Re:
Great strategic move
|
|
Cybergu
|
129 |
48K |
1 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
129
|
48K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
Cybergu
|
175 |
68K |
1 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
175
|
68K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
Cybergu
|
175 |
68K |
1 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
175
|
68K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Ann: FXL - FY20 financial results briefing
|
|
Cybergu
|
356 |
87K |
1 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
356
|
87K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
Cybergu
|
175 |
68K |
0 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
175
|
68K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
Cybergu
|
438 |
149K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
438
|
149K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives TGA approval for COVID19 antibody test
|
|
Cybergu
|
136 |
47K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
136
|
47K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives TGA approval for COVID19 antibody test
|
|
Cybergu
|
136 |
47K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
136
|
47K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Pause in Trading
|
|
Cybergu
|
38 |
12K |
3 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
Cybergu
|
175 |
68K |
2 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
175
|
68K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Broker Target Price of $0.65
|
|
Cybergu
|
8 |
3.3K |
1 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
8
|
3.3K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Mastercard / Dividends / BNPL ^
|
|
Cybergu
|
216 |
49K |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
216
|
49K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Broker Target Price of $0.65
|
|
Cybergu
|
8 |
3.3K |
4 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
8
|
3.3K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Broker Target Price of $0.65
|
|
Cybergu
|
8 |
3.3K |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
8
|
3.3K
|
0
|
|
ASX - By Stock
|
HUM |
Re:
Mastercard / Dividends / BNPL ^
|
|
Cybergu
|
216 |
49K |
0 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
216
|
49K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
Cybergu
|
175 |
68K |
2 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
175
|
68K
|
2
|
|
ASX - By Stock
|
HUM |
Re:
Mastercard / Dividends / BNPL ^
|
|
Cybergu
|
216 |
49K |
3 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
216
|
49K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
Cybergu
|
1.3K |
593K |
1 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
1.3K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
Cybergu
|
58 |
20K |
5 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
Cybergu
|
58 |
20K |
2 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
Cybergu
|
58 |
20K |
1 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Dog Stock
|
|
Cybergu
|
194 |
46K |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
194
|
46K
|
0
|
|